Levitan N - Search Results

1

Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancer.

Hainsworth JD, Levitan N, Wampler GL, Belani CP, Seyedsadr MS, Randolph J, Schacter LP, Greco FA. Hainsworth JD, et al. Among authors: levitan n. J Clin Oncol. 1995 Jun;13(6):1436-42. doi: 10.1200/JCO.1995.13.6.1436. J Clin Oncol. 1995. PMID: 7751890 Clinical Trial.

2

A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.

Levitan N, Dowlati A, Craffey M, Tahsildar H, MacKay W, McKenney J, Remick SC. Levitan N, et al. Lung Cancer. 1998 Dec;22(3):227-34. doi: 10.1016/s0169-5002(98)00087-7. Lung Cancer. 1998. PMID: 10048475 Clinical Trial.

3

Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.

Levitan N, Dowlati A, Shina D, Craffey M, Mackay W, DeVore R, Jett J, Remick SC, Chang A, Johnson D. Levitan N, et al. J Clin Oncol. 2000 Mar;18(5):1102-9. doi: 10.1200/JCO.2000.18.5.1102. J Clin Oncol. 2000. PMID: 10694563 Clinical Trial.

4

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, Levitan N, Gressot L, Vincent M, Burkes R, Coughlin S, Kim Y, Berille J. Shepherd FA, et al. Among authors: levitan n. J Clin Oncol. 2000 May;18(10):2095-103. doi: 10.1200/JCO.2000.18.10.2095. J Clin Oncol. 2000. Corrected and republished in: J Clin Oncol. 2023 May 20;41(15):2673-2681. doi: 10.1200/JCO.22.02545. PMID: 10811675 Corrected and republished. Clinical Trial.

5

Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trials.

Dowlati A, Crosby L, Remick SC, Makkar V, Levitan N. Dowlati A, et al. Among authors: levitan n. Lung Cancer. 2001 May;32(2):155-62. doi: 10.1016/s0169-5002(00)00220-8. Lung Cancer. 2001. PMID: 11325486 Review.

6

Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology Group.

Belani CP, Adak S, Aisner S, Stella PJ, Levitan N, Johnson DH; Eastern Cooperative Oncology Group. Belani CP, et al. Among authors: levitan n. Clin Lung Cancer. 2004 Jul;6(1):43-7. doi: 10.3816/clc.2004.n.020. Clin Lung Cancer. 2004. PMID: 15310416 Clinical Trial.

7

A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.

Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, Johnson DH. Horn L, et al. Among authors: levitan n. J Thorac Oncol. 2009 Apr;4(4):527-33. doi: 10.1097/JTO.0b013e31819c7daf. J Thorac Oncol. 2009. PMID: 19240650 Free PMC article. Clinical Trial.

8

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy.

Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, Levitan N, Gressot L, Vincent M, Burkes R, Coughlin S, Kim Y, Berille J. Shepherd FA, et al. Among authors: levitan n. J Clin Oncol. 2023 May 20;41(15):2673-2681. doi: 10.1200/JCO.22.02545. J Clin Oncol. 2023. PMID: 37196430

9

Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.

Dowlati A, Levitan N, Gordon NH, Hoppel CL, Gosky DM, Remick SC, Ingalls ST, Berger SJ, Berger NA. Dowlati A, et al. Among authors: levitan n. Cancer Chemother Pharmacol. 2001;47(2):141-8. doi: 10.1007/s002800000211. Cancer Chemother Pharmacol. 2001. PMID: 11269740 Clinical Trial.

10

Combination chemotherapy with topotecan for non-small cell lung cancer.

Dowlati A, Levitan N. Dowlati A, et al. Among authors: levitan n. Lung Cancer. 2003 Aug;41 Suppl 4:S23-6. doi: 10.1016/s0169-5002(03)90522-8. Lung Cancer. 2003. PMID: 14565511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page